Skip to content

ATPU(Automatic Tissue Processing unit) ACPU-100

by Bsl Co.

ATPU(Automatic Tissue Processing unit) ACPU-100 is a Class II device made by Bsl Co., listed under FDA premarket submission BK220715 and listed in FDA GUDID since 11 May 2023 (UDI-DI 08800080260019), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) BK220715

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number08800080260019 UDI-DI Date11 May 2023ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberBK220715 Date—StatusActive

Official records

Across registries

2 registries list this device

  • FDA premarket submission BK220715 Active
  • FDA GUDID UDI-DI 08800080260019 listed 11 May 2023 Listed

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
ATPU(Automatic Tissue Processing unit)
Generic name
Autologous adipose tissue reinjection set
Model / reference
ACPU-100
Primary DI / UDI-DI
08800080260019
FDA product code
QKL
GMDN term
Autologous adipose tissue reinjection set
Device class
Class II
Regulation number
878.5040
GUDID distribution status
In Commercial Distribution

Related devices

Category: Autologous adipose tissue reinjection set

Similar devices

Other devices filed under FDA product code QKL (Lipoaspirate Washing System For Aesthetic Body Contouring).

Other devices from Bsl Co.

See all devices from Bsl Co. →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (8, all answered No)